Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00239980

Recruitment Status : Completed

First Posted : October 17, 2005

Last Update Posted : February 3, 2010

Sponsor:

Collaborator:

Pfizer

Information provided by:

Ontario Clinical Oncology Group (OCOG)

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	January 2010
Actual Study Completion Date :	January 2010

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Rutjes AW, Porreca E, Candeloro M, Valeriani E, Di Nisio M. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database Syst Rev. 2020 Dec 18;12:CD008500. doi: 10.1002/14651858.CD008500.pub5.

To Top